Shelter Pharma Limited (BOM:543963)
37.90
+2.87 (8.19%)
At close: Jan 21, 2026
Shelter Pharma Revenue
Shelter Pharma had revenue of 332.93M INR in the half year ending September 30, 2025, with 72.39% growth. This brings the company's revenue in the last twelve months to 598.96M, up 33.79% year-over-year. In the fiscal year ending March 31, 2025, Shelter Pharma had annual revenue of 506.60M with 26.58% growth.
Revenue (ttm)
598.96M
Revenue Growth
+33.79%
P/S Ratio
1.03
Revenue / Employee
8.68M
Employees
69
Market Cap
619.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 506.60M | 106.37M | 26.58% |
| Mar 31, 2024 | 400.23M | 38.70M | 10.70% |
| Mar 31, 2023 | 361.53M | 60.97M | 20.29% |
| Mar 31, 2022 | 300.56M | 75.72M | 33.68% |
| Mar 31, 2021 | 224.83M | -75.82M | -25.22% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mangalam Drugs & Organics | 2.38B |
| Makers Laboratories | 1.31B |
| Godavari Drugs | 1.06B |
| Accretion Pharmaceuticals | 826.43M |
| Onyx Biotec | 663.87M |
| Biofil Chemicals and Pharmaceuticals | 455.49M |
| Amwill Health Care | 386.31M |
| Phaarmasia | 335.76M |